arrow
A

Antonio De Vincentis

internal medicine unit, fondazione policlinico universitario campus bio-medico
H指数:24
被引数:1,995

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ultrasound-derived visceral adipose tissue as a reliable marker of hepato-metabolic risk in patients with MASLD

基于超声的内脏脂肪组织作为MASLD患者肝代谢风险的可靠标志物

2025-12-020
OAAI
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world

奥贝胆酸治疗原发性胆汁性胆管炎的长期疗效、安全性及肝脏硬度动态变化:真实世界研究

2025-05-270
OA
Deprescribing psychoactive drugs in older orthogeriatric patients: findings from the GIOG2.0 Italian survey (vol 25, 138, 2025)
2025-03-290
OAAI
Fibrate-Oca (FI-OCA) Study-a Global snapshot of PBC practice around the Globe
2025-03-010
PRE
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease (vol 30, pg pages3614, 2024)

分区间多基因风险评分识别不同类型的代谢功能障碍相关脂肪性肝病(vol 30, pg pages3614, 2024)

2025-01-160
OA
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease

划分的多基因风险评分可识别代谢功能障碍相关的脂肪性肝病的不同类型

2024-12-091
OAAI
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

数据驱动的聚类分析确定不同类型的代谢功能障碍相关的脂肪性肝病

2024-12-090
OAAI
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study
2024-07-060
OAAI
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients

肝脏和脾脏的声辐射强制冲动,结合新比率评分中的脾脏尺寸和血小板计数,可识别补偿良好的肝硬化患者的高危食管静脉曲张

2024-03-251
OAAI
Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population

第一步FIB4 EASL途径对普通人群中脂肪性肝病风险分层的准确性和可持续性较差

2024-03-183
PRE